TABLE 3.
Univariate analysis of fall risk and tumour‐related blood indices, muscle mass.
| Variable | Low‐risk group (n = 78) | Intermediate‐to‐high‐risk group (n = 83) | Z/t | p‐value |
|---|---|---|---|---|
| Blood indices | ||||
| WBC/109 · L−1 | 5.6 (4.4,7.02) | 6 (4.7,6.9) | −0.695 | 0.487 |
| RBC/1012 · L−1 | 4.10 ± 0.49 | 3.86 ± 0.62 | 2.777 | 0.006 |
| Haemoglobin/g · L−1 | 125 (117,138) | 117 (107,131) | −3.353 | 0.001 |
| PLT/109 · L−1 | 178 (135.8225.5) | 206 (169,267) | −3.019 | 0.003 |
| CEA/ng | 2.2 (1.5,4.1) | 2.7 (1.7,4.8) | −1.341 | 0.180 |
| Muscle mass | ||||
| RF‐MLT/mm | 8.75 (7.5,10.78) | 7.8 (6.2,9.2) | −2.289 | 0.022 |
| RVI‐MLT/mm | 8.75 (7.5,10.78) | 7.5 (6,9.6) | −3.221 | 0.001 |
| RF‐CSA/cm2 | 2.6 (1.7,3.7) | 2.2 (1.6,3.1) | −1.838 | 0.066 |
| LF‐MLT/mm | 8.85 (7,10.5) | 7.7 (5.9,9.3) | −2.952 | 0.003 |
| LVI‐MLT/mm | 8.8 (7.7,10.6) | 7.4 (5.7,8.6) | −4.300 | <0.001 |
| LF‐CSA/cm2 | 2.5 (1.8,3.5) | 2.1 (1.4,3.1) | −2.348 | 0.019 |
Abbreviations: CEA, carcinoembryonic antigen; LF‐CSA, left cross‐sectional area; LF‐MLT, left muscle rectus femoris; PLT, platelets; RBC, red blood cells; WBC, white blood cells.